Stephen A Udem
Overview
Explore the profile of Stephen A Udem including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
24
Citations
623
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Clarke D, Nasar F, Chong S, Johnson J, Coleman J, Lee M, et al.
J Virol
. 2014 Apr;
88(12):6690-701.
PMID: 24696472
Unlabelled: In previous work, a prototypic recombinant vesicular stomatitis virus Indiana serotype (rVSIV) vector expressing simian immunodeficiency virus (SIV) gag and human immunodeficiency virus type 1 (HIV-1) env antigens protected...
2.
Witko S, Johnson J, Kalyan N, Felber B, Pavlakis G, Sidhu M, et al.
J Virol Methods
. 2009 Nov;
164(1-2):43-50.
PMID: 19941901
Propagation-defective vesicular stomatitis virus (VSV) vectors that encode a truncated G protein (VSV-Gstem) or lack the G gene entirely (VSV-DeltaG) are attractive vaccine vectors because they are immunogenic, cannot replicate...
3.
Johnson J, Coleman J, Kalyan N, Calderon P, Wright K, Obregon J, et al.
Vaccine
. 2009 May;
27(22):2930-9.
PMID: 19428903
Recombinant vesicular stomatitis viruses (rVSVs) are being developed as potential HIV-1 vaccine candidates. To characterize the in vivo replication and dissemination of rVSV vectors in mice, high doses of a...
4.
Cooper D, Wright K, Calderon P, Guo M, Nasar F, Johnson J, et al.
J Virol
. 2007 Oct;
82(1):207-19.
PMID: 17942549
Recombinant vesicular stomatitis virus (rVSV) has shown great potential as a new viral vector for vaccination. However, the prototypic rVSV vector described previously was found to be insufficiently attenuated for...
5.
Elliott M, Chen T, Terio N, Chong S, Abdullah R, Luckay A, et al.
Vaccine
. 2007 Sep;
25(41):7132-44.
PMID: 17850933
Respiratory syncytial virus (RSV) is a major cause of acute respiratory tract disease in humans. Towards development of a prophylactic vaccine, we genetically engineered Venezuelan equine encephalitis virus (VEEV) replicons...
6.
Parks C, Latham T, Cahill A, ONeill R, Passarotti C, Buonagurio D, et al.
Virology
. 2007 Jun;
367(2):275-87.
PMID: 17599381
Widespread use of a live-attenuated influenza vaccine (LAIV) in the United States (licensed as FluMist) raises the possibility that vaccine viruses will contribute gene segments to the type A influenza...
7.
Coleman J, Ogin-Wilson E, Johnson J, Nasar F, Zamb T, Clarke D, et al.
J Virol Methods
. 2007 Mar;
143(1):55-64.
PMID: 17382412
Assessment of in vivo viral replication of live attenuated recombinant vesicular stomatitis virus (rVSV) vaccine vector candidates encoding HIV gag requires comprehensive preclinical safety studies, and development of sensitive assays...
8.
Kowalski J, Adkins K, Gangolli S, Ren J, Arendt H, DeStefano J, et al.
Vaccine
. 2007 Jan;
25(12):2296-305.
PMID: 17239997
The safety of a propagation-defective Venezuelan equine encephalitis virus (VEEV) replicon particle vaccine was examined in mice. After intracranial inoculation we observed approximately 5% body weight loss, modest inflammatory changes...
9.
Clarke D, Nasar F, Lee M, Johnson J, Wright K, Calderon P, et al.
J Virol
. 2006 Dec;
81(4):2056-64.
PMID: 17151112
A variety of rational approaches to attenuate growth and virulence of vesicular stomatitis virus (VSV) have been described previously. These include gene shuffling, truncation of the cytoplasmic tail of the...
10.
Johnson J, Nasar F, Coleman J, Price R, Javadian A, Draper K, et al.
Virology
. 2006 Nov;
360(1):36-49.
PMID: 17098273
Although vesicular stomatitis virus (VSV) neurovirulence and pathogenicity in rodents have been well studied, little is known about VSV pathogenicity in non-human primates. To address this question, we measured VSV...